Imported Drugs: Health Ministry Seeks Comments on Shelf-Life Rule
The Union Health Ministry is inviting public feedback on a proposed change to rules for imported medicines. This aims to make it easier to bring certain drugs into India.
Source: PIB All ReleasesThe Union Ministry of Health and Family Welfare has invited public comments on a draft amendment to the Drugs Rules, 1945. This amendment aims to rationalise the residual shelf-life requirement for imported drugs. Currently, imported drugs must have at least 60% of their shelf-life remaining when they arrive in India. The proposed change suggests that for drugs with a shelf-life of less than 18 months, a minimum of three months of shelf-life should remain at the time of import. For drugs with a shelf-life of 18 months or more, the existing 60% rule will continue. This move by the Union Ministry of Health and Family Welfare seeks to address challenges faced by importers and ensure availability of essential medicines. Stakeholders can submit their comments and suggestions to the Union Ministry of Health and Family Welfare within 30 days from the notification date.
This development is important for aspirants studying Indian Polity and Economy, particularly for topics related to government policy, health regulations, and trade. It highlights the government's efforts to streamline import processes and ensure drug availability, which can be linked to UPSC GS Paper II (Governance, Health) and SSC General Awareness. Understanding such regulatory changes is crucial for questions on administrative reforms and public health initiatives.
- Union Ministry of Health and Family Welfare invited comments on draft amendment to Drugs Rules, 1945.
- The amendment focuses on residual shelf-life requirements for imported drugs.
- Current rule requires 60% shelf-life remaining for imported drugs.
- Proposed change: drugs with less than 18 months shelf-life need 3 months remaining.
- Drugs with 18 months or more shelf-life will still follow the 60% rule.
- Public comments are invited for a period of 30 days.
These rules were framed under the Drugs and Cosmetics Act, 1940. They provide detailed regulations for the manufacture, sale, distribution, and import of drugs and cosmetics in India. The rules cover various aspects like licensing, quality control, labelling, and standards for different categories of drugs. They are regularly updated to adapt to new scientific advancements and public health needs.
Shelf-life refers to the period during which a drug or product is expected to remain stable and effective, retaining its quality and safety when stored under specified conditions. It is determined by stability studies conducted by manufacturers and is indicated by an expiry date. After this period, the drug may lose potency or become unsafe for use.
This is a ministry of the Government of India responsible for health policy, family planning, and various health-related programs. It formulates and implements national health policies, manages public health services, and regulates drugs and medical devices. Its headquarters are in New Delhi. It plays a crucial role in ensuring healthcare access and quality across the country.
Exams often ask about key government ministries, their functions, and important acts/rules related to public health. Be prepared for questions on the Drugs and Cosmetics Act, CDSCO, and recent policy changes in the health sector.
Remember '60-18-3': 60% for 18+ months shelf-life, 3 months for less than 18 months shelf-life.
Frequently Asked Questions
What is the current shelf-life requirement for imported drugs in India?
Currently, imported drugs must have at least 60% of their total shelf-life remaining at the time they are imported into India. This rule applies to all types of imported medicines.
What is the proposed change to the shelf-life rule for imported drugs?
The proposed change suggests that for drugs with a total shelf-life of less than 18 months, a minimum of three months of shelf-life should remain when imported. For drugs with 18 months or more shelf-life, the 60% rule will continue.
Why is the Union Health Ministry amending the shelf-life requirement for imported drugs?
The Union Health Ministry is amending the rule to rationalise the requirement, aiming to address challenges faced by importers and ensure better availability of essential medicines in India. It seeks to streamline the import process.